Evidence map›Paper›PMID 23199127›Full record

ArticleThe EPMA journal2011

Epidemiology and prevention of hypertension in Japanese: how could Japan get longevity?

Katsuyuki Miura

Abstract read
In one paragraph

Article in The EPMA journal, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Triple A Plus (AAAAmerican journal of hematology · 2025
    Article
  3. Article
  4. Observational
  5. Article
  6. Trends in blood pressure and hypertension among older adults and oldest-old individuals in China between 2008-2018.Hypertension research : official journal of the Japanese Society of Hypertension · 2023
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Epidemiology of hypertension in Japan: beyond the new 2019 Japanese guidelines.Hypertension research : official journal of the Japanese Society of Hypertension · 2020
    Review
  13. Review
  14. Disabled life expectancy with and without stroke: a 10-year Japanese prospective cohort study.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2019
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Katsuyuki MiuraDepartment of Health Science, Shiga University of Medical Science, Seta-Tsukinowa-cho, Otsu, Shiga 520-2192 Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Japan is one of the countries with the longest longevity in the world, and it was accomplished by a drastic decline in stroke mortality from 1960's. The decline in stroke mortality would be largely explained by a population-wide decreasing trend in blood pressure (BP) level, because higher BP has been the strongest risk factor of stroke; about 20% of total deaths can be explained by higher BP above optimal in Japan. Decreasing trend in BP occurred both in men and women in all age-groups, which cannot be fully explained by the widespread use of anti-hypertensive agents. The most probable reason for the population-wide BP decline in Japan would be a large decline in dietary salt intake after 1950's. However, other factors including obesity, high alcohol intake, and unfavorable dietary habits could increase BP level of Japanese again.

Identifiers

PMID23199127
PMCPMC3405372

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.